טוען...
Aβ seeding potency peaks in the early stages of cerebral β‐amyloidosis
Little is known about the extent to which pathogenic factors drive the development of Alzheimer's disease (AD) at different stages of the long preclinical and clinical phases. Given that the aggregation of the β‐amyloid peptide (Aβ) is an important factor in AD pathogenesis, we asked whether Aβ...
שמור ב:
| הוצא לאור ב: | EMBO Rep |
|---|---|
| Main Authors: | , , , , , , , , , , , , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
John Wiley and Sons Inc.
2017
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5579388/ https://ncbi.nlm.nih.gov/pubmed/28701326 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.15252/embr.201744067 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|